Th17 Cells in Cancer: The Ultimate Identity Crisis
Stefanie R. Bailey(Medical University of South Carolina), Chrystal M. Paulos(Medical University of South Carolina)
Cited by 327
Related Papers
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion
|JCI Insight|2017|69
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8 <sup>+</sup> T cells
|European Journal of Immunology|2020|64